Position in CGEN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$571
+$3 QoQ
Shares Held
267
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 82 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Addison Advisors LLC holds $20,811 across 8 Biotechnology names. CGEN ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
209 | $5,741 | |
| 2 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 3 | ADMA |
Adma Biologics, Inc.
|
500 | $4,185 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 6 | INCY |
Incyte Corp
|
6 | $680 | |
| 7 | CGEN |
Compugen Ltd
This page
|
267 | $571 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
5 | $272 |
All Filings in CGEN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $571 | 267 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $568 | 267 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $408 | 267 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $392 | 267 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $475 | 267 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $389 | 267 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $408 | 267 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $483 | 267 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $448 | 267 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $688 | 267 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $528 | 267 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $248 | 267 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,356 | 2,067 | Shares | Sole | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||